Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 1
1949 4
1950 2
1951 1
1953 2
1954 2
1955 1
1956 3
1959 1
1961 2
1964 3
1965 4
1966 7
1967 4
1968 11
1969 4
1970 4
1971 9
1972 6
1973 5
1974 9
1975 4
1976 8
1977 19
1978 8
1979 12
1980 8
1981 15
1982 10
1983 8
1984 5
1985 13
1986 12
1987 7
1988 8
1989 7
1990 6
1991 9
1992 11
1993 11
1994 13
1995 14
1996 11
1997 13
1998 11
1999 14
2000 10
2001 13
2002 20
2003 10
2004 15
2005 16
2006 16
2007 31
2008 20
2009 21
2010 30
2011 23
2012 26
2013 17
2014 22
2015 14
2016 16
2017 13
2018 12
2019 5
2020 13
2021 16
2022 15
2023 15
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

713 results

Results by year

Filters applied: . Clear all
Page 1
Cachexia: A systemic consequence of progressive, unresolved disease.
Ferrer M, Anthony TG, Ayres JS, Biffi G, Brown JC, Caan BJ, Cespedes Feliciano EM, Coll AP, Dunne RF, Goncalves MD, Grethlein J, Heymsfield SB, Hui S, Jamal-Hanjani M, Lam JM, Lewis DY, McCandlish D, Mustian KM, O'Rahilly S, Perrimon N, White EP, Janowitz T. Ferrer M, et al. Among authors: ayres js. Cell. 2023 Apr 27;186(9):1824-1845. doi: 10.1016/j.cell.2023.03.028. Cell. 2023. PMID: 37116469 Free PMC article. Review.
Eating-disorder psychopathology in female athletes and non-athletes: A meta-analysis.
Chapa DAN, Johnson SN, Richson BN, Bjorlie K, Won YQ, Nelson SV, Ayres J, Jun D, Forbush KT, Christensen KA, Perko VL. Chapa DAN, et al. Among authors: ayres j. Int J Eat Disord. 2022 Jul;55(7):861-885. doi: 10.1002/eat.23748. Epub 2022 Jun 4. Int J Eat Disord. 2022. PMID: 35665528 Free PMC article. Review.
Milrinone.
Ayres JK, Maani CV. Ayres JK, et al. 2023 Aug 28. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 Aug 28. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 30422538 Free Books & Documents.
Paired microbiome and metabolome analyses associate bile acid changes with colorectal cancer progression.
Fu T, Huan T, Rahman G, Zhi H, Xu Z, Oh TG, Guo J, Coulter S, Tripathi A, Martino C, McCarville JL, Zhu Q, Cayabyab F, Low B, He M, Xing S, Vargas F, Yu RT, Atkins A, Liddle C, Ayres J, Raffatellu M, Dorrestein PC, Downes M, Knight R, Evans RM. Fu T, et al. Among authors: ayres j. Cell Rep. 2023 Aug 29;42(8):112997. doi: 10.1016/j.celrep.2023.112997. Epub 2023 Aug 22. Cell Rep. 2023. PMID: 37611587 Free PMC article.
Immunometabolism of infections.
Ayres JS. Ayres JS. Nat Rev Immunol. 2020 Feb;20(2):79-80. doi: 10.1038/s41577-019-0266-9. Nat Rev Immunol. 2020. PMID: 31892735 Review. No abstract available.
Surviving COVID-19: A disease tolerance perspective.
Ayres JS. Ayres JS. Sci Adv. 2020 Apr 29;6(18):eabc1518. doi: 10.1126/sciadv.abc1518. eCollection 2020 May. Sci Adv. 2020. PMID: 32494691 Free PMC article. No abstract available.
Cooperative defenses during enteropathogenic infection.
Troha K, Ayres JS. Troha K, et al. Among authors: ayres js. Curr Opin Microbiol. 2022 Feb;65:123-130. doi: 10.1016/j.mib.2021.11.003. Epub 2021 Nov 27. Curr Opin Microbiol. 2022. PMID: 34847524 Free PMC article. Review.
The Biology of Physiological Health.
Ayres JS. Ayres JS. Cell. 2020 Apr 16;181(2):250-269. doi: 10.1016/j.cell.2020.03.036. Cell. 2020. PMID: 32302569 Free PMC article. Review.
Microbiota Metabolites in Health and Disease.
McCarville JL, Chen GY, Cuevas VD, Troha K, Ayres JS. McCarville JL, et al. Among authors: ayres js. Annu Rev Immunol. 2020 Apr 26;38:147-170. doi: 10.1146/annurev-immunol-071219-125715. Annu Rev Immunol. 2020. PMID: 32340573 Review.
Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.
Humbert M, Beasley R, Ayres J, Slavin R, Hébert J, Bousquet J, Beeh KM, Ramos S, Canonica GW, Hedgecock S, Fox H, Blogg M, Surrey K. Humbert M, et al. Among authors: ayres j. Allergy. 2005 Mar;60(3):309-16. doi: 10.1111/j.1398-9995.2004.00772.x. Allergy. 2005. PMID: 15679715 Clinical Trial.
713 results